Northwestern Memorial's Bluhm Cardiovascular Institute Trials Implantable Device to Manage Congestive Heart Failure SymptomsOctober 09, 2008CHICAGO - Northwestern Memorial's Bluhm Cardiovascular Institute is one of seven programs in the country participating in new study aimed at improving the heart's pumping action and helping to manage congestive heart failure symptoms. The US PARACHUTE trial tests the effectiveness of placing a small device in the left ventricle, or main pumping chamber of the heart. Northwestern Memorial physicians recently implanted the first study participant with the device; the individual is the sixth person in the United States to undergo the procedure. Congestive heart failure is a condition in which the heart can't pump enough blood to the body's other organs and has a variety of causes. The US PARACHUTE trial looks at patients whose congestive heart failure was caused by a previous heart attack. Over time the increased workload of the heart can lead to a change called remodeling, which is the enlargement and thinning of the left ventricle. In time this can lead to more severe heart disease. Many heart failure patients take a combination of drugs to treat heart failure symptoms such as shortness of breath or difficulty breathing, however they do not address remodeling which is the underlying cause. "The goal of the study is to return the ventricle to a normal shape, decrease heart failure symptoms and prevent the heart from further deterioration," said Charles Davidson, MD, principle investigator for the study, chief of the cardiac catheterization lab at the Bluhm Cardiovascular Institute and professor of medicine at Northwestern University's Feinberg School of Medicine.
The study device, developed and manufactured by CardioKinetix of Menlo Park, California, resembles an upside down parachute, is implanted in the left ventricle using a catheter which is inserted via a tube in the participant's leg artery. This may eliminate the need for open-heart surgery and general anesthesia and may also allow for faster recovery times. Congestive heart failure affects approximately 5.3 million people in the United States. Symptoms of heart failure diminish an individual's quality of life. "Our hope is that the device is may be able to improve each patient's quality of life and longevity," commented Dr. Davidson. Northwestern Memorial Hospital | |||||||||||||||||||||
|
Related Congestive Heart Failure Current Events and Congestive Heart Failure News Articles Simple Model Predicts Those at Risk for Chronic Kidney Disease Traditionally, doctors have had no clear way to predict which of their patients might be headed down the road to chronic kidney disease (CKD). First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure. Study reveals continued damage from banned obesity drug Fenfluramine, the appetite suppressant drug banned in the US in 1997 due to fears over its links to heart conditions, has been shown to have serious long-term effects. In first national survey, patients give low scores to hospitals The quality of hospitals across the U.S. is inconsistent. To address this issue, the federal government and private organizations have begun to publicly report data, such as how well hospitals treat certain conditions. Stress tests to confirm need for cardiac stent not occurring in most patients, new study finds UCSF researchers investigating the appropriate use of procedures to open narrowed coronary arteries -- such as angioplasty and stenting -- found that less than half of Medicare patients had documented noninvasive stress testing prior to elective percutaneous coronary intervention, or PCI, the clinical name for such procedures. Depressed dialysis patients more likely to be hospitalized or die, researcher finds Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found. UT Southwestern cardiologists find physical exams just as good for assessing heart failure Patient history and physical examination, traditionally the cornerstone diagnostic tool for medical care, may still be among the most accurate and cost-efficient methods to assess patients with congestive heart failure, UT Southwestern Medical Center researchers have found. Depressed dialysis patients more likely to be hospitalized or die, researcher finds Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found. Class of diabetes drugs carries significant cardiovascular risks A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members. Air pollution damages more than lungs: Heart and blood vessels suffer too As athletes from around the world compete in the Beijing Olympics, many are on alert for respiratory problems caused by air pollution. They should also be concerned about its toxic effects on the heart and cardiovascular system, mounting research shows. More Congestive Heart Failure Current Events and Congestive Heart Failure News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||